Product Details

Arti-Cell Forte Suspension for Injection for Horses

• MA holder: Boehringer Ingelheim Vetmedica GmbH
• VM number: EU/2/18/228/001
• Territory: Northern Ireland
• Associated documents:
  • Available from EU Union Product Database
• Date of issue: 29/03/2019
• Authorisation route: Centralised
• Active substances:
  • Chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells
• Controlled drug: No
• Target species:
  • Horses
• Distribution category: POM-V